EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Model-informed drug development in pediatric, pregnancy and geriatric drug development: States of the art and future

Yue-E Wu, Yuan-Yuan Zheng, Qiu-Yue Li, Bu-Fan Yao, Jing Cao, Hui-Xin Liu, Guo-Xiang Hao, John van den Anker, Yi Zheng, Wei Zhao

Advanced Drug Delivery Reviews · 2024-08 · 211 · 115364

DOI: 10.1016/j.addr.2024.115364 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2024-08. Verfasst von Yue-E Wu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Institute of Clinical Pharmacology, Key Laboratory of Chemical Biology (Ministry of Education), NMPA Key Laboratory …. Hauptthemen laut MEDLINE: Drug Development. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 252 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The challenges of drug development in pediatric, pregnant and geriatric populations are a worldwide concern shared by regulatory authorities, pharmaceutical companies, and healthcare professionals. Model-informed drug development (MIDD) can integrate and quantify real-world data of physiology, pharmacology, and disease processes by using modeling and simulation techniques to facilitate decision-making in drug development. In this article, we reviewed current MIDD policy updates, reflected on the integrity of physiological data used for MIDD and the effects of physiological changes on the drug PK, as well as summarized current MIDD strategies and applications, so as to present the state of the art of MIDD in pediatric, pregnant and geriatric populations. Some considerations are put forth for the future improvements of MIDD including refining regulatory considerations, improving the integrity of physiological data, applying the emerging technologies, and exploring the application of MIDD in new therapies like gene therapies for special populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug DevelopmentHumansPregnancyFemaleChildAgedModels, Biological

Stichwörter der Autor:innen

Future improvementsGeriatricsMIDD applicationsPediatricsPhysiological changesPoliciesPregnancy

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, Institute of Clinical Pharmacology, Key Laboratory of Chemical Biology (Ministry of Education), NMPA Key Laboratory for Clinical Research and Evaluation of Innovative Drug, School of Pha…
  • Division of Clinical Pharmacology, Children's National Medical Center, Washington, DC, USA; Departments of Pediatrics, Pharmacology & Physiology, George Washington University, School of Medicine and Health Sciences, Was…

Zitieren

APA

Wu, Y. E., Zheng, Y. Y., Li, Q. Y., Yao, B. F., Cao, J., Liu, H. X., Hao, G. X., van den Anker, J., Zheng, Y., & Zhao, W. (2024). Model-informed drug development in pediatric, pregnancy and geriatric drug development: States of the art and future. Advanced Drug Delivery Reviews, 211, 115364. https://doi.org/10.1016/j.addr.2024.115364

Vancouver

Wu YE, Zheng YY, Li QY, Yao BF, Cao J, Liu HX, et al. Model-informed drug development in pediatric, pregnancy and geriatric drug development: States of the art and future. Advanced Drug Delivery Reviews. 2024;211:115364. doi:10.1016/j.addr.2024.115364

BibTeX
@article{Wu2024,
  author = {Wu, Yue-E and Zheng, Yuan-Yuan and Li, Qiu-Yue and Yao, Bu-Fan and Cao, Jing and Liu, Hui-Xin and Hao, Guo-Xiang and van den Anker, John and Zheng, Yi and Zhao, Wei},
  title = {Model-informed drug development in pediatric, pregnancy and geriatric drug development: States of the art and future},
  journal = {Advanced Drug Delivery Reviews},
  year = {2024},
  volume = {211},
  pages = {115364},
  doi = {10.1016/j.addr.2024.115364}
}
Kostenlos starten →